Dimerix

Dimerix Net Debt/FCF

The Net Debt to Free Cash Flow Ratio of Dimerix (DXB.AX) as of Oct 11, 2026 is 0.31. In the previous year, Net Debt to Free Cash Flow Ratio was -1.75 — a change of -117.59% (higher).

Net Debt/FCF

0.31

YoY

-117.59%

Last updated:

Net Debt to Free Cash Flow Ratio of Dimerix is 2026 0.31 . Net Debt to Free Cash Flow Ratio of Dimerix was 2025 -1.75 . It decreases by -117.59% higher compared to the previous year.

The Dimerix Net Debt/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/FCF
Date
Net Debt/FCF
Jan 1, 2019
0.90 AUD
Jan 1, 2020
1.42 AUD
Jan 1, 2021
0.02 AUD
Jan 1, 2022
0.71 AUD
Jan 1, 2023
0.16 AUD
Jan 1, 2024
3.13 AUD
Jan 1, 2025
-1.75 AUD
Jan 1, 2026
0.31 AUD
The Dimerix Net Debt/FCF history
YEARNet Debt/FCFYoY
0.31-117.59%
-1.75-155.76%
3.13+1,861.15%
0.16-77.52%
0.71+2,829.91%
0.02-98.29%
1.42+58.89%
0.90-54.00%
1.95+61.89%
1.20—
Access this data via the Eulerpool API

Dimerix Stock analysis

What does Dimerix do? Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dimerix stock

Net Debt to Free Cash Flow Ratio of Dimerix is 0.31 in 2026.

Net Debt to Free Cash Flow Ratio of Dimerix changed from -1.75 to 0.31, representing a -117.59% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to Free Cash Flow Ratio Dimerix since 2006 – with annual values, charts, and detailed analysis.

Net Debt/FCF indicates how many years it would take to repay net debt using free cash flow. Lower ratios suggest faster deleveraging potential.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Free Cash Flow Ratio's Dimerix with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Dimerix

All Key Metrics — Dimerix